Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
38.71 USD | +3.03% | +2.79% | -23.52% |
May. 31 | Ionis Reports 'Positive Results' From Studies of Investigational Treatment for Hereditary Angioedema | MT |
May. 31 | Transcript : Ionis Pharmaceuticals, Inc. - Special Call |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.52% | 5.48B | |
+48.70% | 54.63B | |
-6.52% | 39.92B | |
+37.07% | 38.82B | |
+14.18% | 26.86B | |
-11.17% | 26.22B | |
-21.45% | 18.78B | |
+25.49% | 12.21B | |
+0.90% | 12.16B | |
+26.45% | 11.94B |
- Stock Market
- Equities
- IONS Stock
- News Ionis Pharmaceuticals, Inc.
- Transcript : Ionis Pharmaceuticals, Inc. - Analyst/Investor Day